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Purpose Results
There were 41 individual episodes of GIB in 14 pa.ents. The sen.nel bleed occurred within the first year of VAD implant in 13 of 14 (93%) pa.ents. Ten of the fourteen pa.ents (71%) developed a second bleed and all of these subsequent bleeding episodes (100%) were seen within 1 year of the sen.nel bleed. Of the 41 episodes, 33 individual sites were iden.fied using a spectrum of imaging modali.es.
Discussion and Conclusion
Tradi.onal GIB algorithms were designed for medical pa.ents with liWle emphasis on speedy diagnosis and are aimed at most common sites of bleeding seen in the general popula.on. Non--pulsa.le VAD pa.ents with GIB are different; they require modern modali.es aiming at the most common loca.ons of bleeding specific to this popula.on. Our study shows the upper GI tract as the most common site with AVM's being the predominant pathology. U.lizing our algorithm, DBE can be performed upon presenta.on thus elimina.ng the need for further tests and limi.ng the number of PRBC's given to the pa.ent.
Retrospective review of 62 patients with non-pulsatile VAD's over a 7 year period for episodes of GIB. à GIB was defined as: heme positive stool and drop in Hgb≥2g. àAll patients were anticoagulated on either aspirin, Plavix, Coumadin or a combination of these medications and had no bleeding history prior to the initial bleed. àEnd points measured were number of packed red blood cells received and the number of tests performed per episode of GIB. 
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